期刊文献+

RAGE基因多态性与高血压左室肥厚、血清esRAGE水平的相关性研究 被引量:5

A study on the association of RAGE gene polymorphism in patients with essential hypertension and left ventricular hypertrophy and serum levels of esRAGE
下载PDF
导出
摘要 目的探讨晚期糖基化终末产物受体(RAGE)基因Gly82Ser多态性与EH-LVH患者及其血清内源性分泌型RAGE(esRAGE)水平的相关性。方法应用聚合酶链反应-限制性片段多态性(PCR-RLFP)的方法,检测94例EH患者(其中38例伴LVH)及50例对照组RAGE基因Gly82Ser多态性,同时采用ELISA法测定血清esRAGE水平。结果与正常对照组相比,EH组基因型频率和等位基因频率差异无统计学意义(P>0.05);EH-LVH组RAGE基因Gly82Ser位点的GS基因型频率和82Ser等位基因频率明显增高,差异有统计学意义(P<0.05);EH-LVH和EH组Gly82Ser SS基因型血清es-RAGE水平与对照组相比差异显著(P<0.05)。结论 RAGE基因Gly82Ser多态性与EH的发生发展无关;EH-LVH患者RAGE基因Gly82Ser GS基因型和82Ser等位基因增多,提示82Ser等位基因可能是EH-LVH发病的易感基因;RAGE基因Gly82Ser多态性与血清esRAGE水平显著相关。 ObjectiveTo explore the relationships between RAGE gene polymorphism in patients with essential hypertension and left ventricular hypertrophy and serum levels of esRAGE.MethodsThe polymorphisms of RAGE gene were analyzed by PCR-restriction fragment length polymorphism(PCR-RFLP) methods in 94 patients with essential hypertension and 50 healthy controls,and the serum level of esRAGE was determined by enzyme linked immunosorbent assay(ELISA).ResultsNo significant difference was found in alleles and genotype frequencies of RAGE gene Gly82Ser polymorphism between essential hypertension with left ventricular hypertrophy and control group(P0.05).The frequencies of RAGE gene Gly82Ser GS heterozygous genotype and S allele frequency were significantly higher in patients with essential hypertension and left ventricular hypertrophy than those in control group(P0.05).The serum levels of esRAGE were lower in Gly82Ser SS genotype of RAGE gene in patients with essential hypertension and left ventricular hypertrophy than those in control group(P0.05).ConclusionRAGE gene Gly82Ser polymorphism is not associated with EH and EH-LVH patients,Gly82Ser GS heterozygous genotype and 82Ser allele may be associated with EH-LVH patients.A significant relationship has been found between the polymorphism of the RAGE gene and the serum levels of esRAGE.
出处 《中国实用神经疾病杂志》 2011年第3期23-25,共3页 Chinese Journal of Practical Nervous Diseases
关键词 高血压 ESRAGE RAGE 左心室肥厚 基因多态性 Essential hypertension esRAGE RAGE Left ventricular hypertrophy Gene polymorphism
  • 相关文献

参考文献6

  • 1张克巨,李莉,崔天祥.高血压合并左室肥厚患者晚期糖基化产物与血管紧张素Ⅱ的相关性研究[J].中国实用神经疾病杂志,2010,13(3):21-23. 被引量:4
  • 2Laviades C,Varo N,Diez J,et al.Transforming growth factor-β in hypertensives with cardiorenal damage[J].Hypertension,2000,36(5):517-525.
  • 3Hofmann MA,Drury S,Hudson BI,et al.RAGE and arthritis:the G82S polymorphism amplifies the lammatory response[J].Genes Immun,2002,3:123-135.
  • 4Poirier O,Nicaud V,Vionnet N,er al.Polymorphism screening of four genes encoding advanced glycation end product putative receptors.Association study with nephropathy in type 1 diabetic patients[J].Diaberts,2001,50(5):1 214-1 218.
  • 5Harashima A,Yamamoto Y,Cheng C.et al.Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end products:structure,function and expression[J].Biochem J,2006,396:109-115.
  • 6Koyama H,Shoji T,Fukumoto S,et al.Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease[J].Arterioscler Thromb Vasc Biol,2007,27:147-153.

二级参考文献8

  • 1丁同斌,李莉,崔天祥.晚期糖基化终末产物与心血管病关系的研究进展[J].中国实用神经疾病杂志,2007,10(8):140-142. 被引量:2
  • 2廉秋芳,朱继金.高血压左心室肥厚的研究进展[J].实用诊断与治疗杂志,2007,21(1):50-52. 被引量:14
  • 3Lawes CM, Vander Hooms, Rodger A. Global burden of bloodpressure-related disease[J]. Lancet, 2008,371 (9623) : 1513-1518.
  • 4Zhou GH, Li C, Cai L. Adanced glycation end products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta independent pathway[J] . Am J Pathol, 2004, 165: 2033-2043.
  • 5Huang JS, Gu JY, Chen HC, et aI. Ro le of receptor for advanced glycation end product (RAGE) and the JA K-STAT- signaling pathway in AGEs induced collagen production in NRK- 49Fcells[J ]. Cell Biochem, 2001, 81: 102-113.
  • 6Ralica Petrova, Yasuhiko Yamamoto, Katsuhiko Muraki, et al. Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes[J]. Mol Cell Cardiol, 2002,34 : 1425-1431.
  • 7Iribarren C ,Karter AJ ,Go AS , et al . Glycemic control and heart failure among adult patients with diabetes[J]. Circulation,2001, 103: 2668-2673.
  • 8陈磊,文富强.晚期糖基化终末产物在纤维化中的作用机制[J].西部医学,2008,20(3):643-645. 被引量:7

共引文献3

同被引文献27

  • 1何丹,白淑荣.慢性阻塞性肺疾病患者系统性炎症与肺动脉高压的关系研究[J].实用心脑肺血管病杂志,2010,18(12):1768-1769. 被引量:20
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8234
  • 3Devereux RB,Alonsob K,Lutas EM,et al.Echocardiographic assessment of left ventricular hypertrophy comparision to necropsy findings[J].Am J Cordial,1986,57:450.
  • 4Ames RS,Sarau HM,Chambers JK,et al.Human urotensin-Ⅱ is a potent vadioconstrictor and agonist for the orphan receptor GPR14[J].Nature,1999,401 (6750):282-286.
  • 5Douglas SA,Ohlstein EH.Human urotensin-Ⅱ,the most potent mammalian vasoconstrictor identified to date,as a therapeutic target for the management of cardiovascular disease[J].Trends Cardiovasc Med,2000,10(6):229-237.
  • 6Cheung BM,Leung R,Man YB,et al.Plasma concentration of urotensin Ⅱ is raised in hypertension[J].J Hypertens,2004,22:1 341-1 344.
  • 7《中国高血压防治指南修订》委员会.中国高血压防治指南2010[M]北京:人民卫生出版社,2011.
  • 8Basta G. Receptor for advanced glycation endproducts and atherosclerosis:From basic mechanisms to clinical implications[J].Atheroclerosis,2008,(01):9-21.
  • 9Choi KM,Yoo HJ,Kim HY. Association between endogenous secretory RAGE,inflammatory markers and arterial stiffness[J].International Journal of Cardiology,2008.
  • 10Katakami N,Ohtoshi K,Matsuhisa M. Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients[J].Diabetes Care,2005,(11):2716-2721.doi:10.2337/diacare.28.11.2716.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部